We are live on ! Find out more
GA

Gagnon Advisors Portfolio holdings

AUM $136M
1-Year Est. Return 21.55%
This Fund
S&P 500
This Quarter Est. Return
-10.69%
1 Year Est. Return
+21.55%
3 Year Est. Return
+78.18%
5 Year Est. Return
+93.01%
10 Year Est. Return
+1,298.31%
AUM
$142M
AUM Growth
-$14.4M
Cap. Flow
+$7.45M
Cap. Flow %
5.25%
Top 10 Hldgs %
56.62%
Holding
28
New
2
Increased
5
Reduced
2
Closed

Top Buys

Rank Stock Value
1
MXCT icon
MaxCyte
MXCT
+$3.68M
2
AMRC icon
Ameresco
AMRC
+$3.62M
3
OSUR icon
OraSure Technologies
OSUR
+$2.94M
4
ETWO
E2open Parent Holdings
ETWO
+$2.91M
5
VERX icon
Vertex
VERX
+$2.11M

Top Sells

Rank Stock Value
1
WGS icon
GeneDx Holdings
WGS
+$5.25M
2
PSIX
Power Solutions International
PSIX
+$5.06M

Sector Composition

Rank Sector Weight
1 Healthcare 32.79%
2 Technology 27.98%
3 Energy 17.2%
4 Industrials 16.49%
5 Real Estate 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPD icon
1
Enterprise Products Partners
EPD
$82.5B
$11.6M 8.18%
339,877
WGS icon
2
GeneDx Holdings
WGS
$2.05B
$11.3M 7.94%
127,062
-60,556
-32% -$5.25M
AL
3
DELISTED
Air Lease Corp
AL
$9.49M 6.69%
196,479
PSIX
4
Power Solutions International
PSIX
$641M
$8.18M 5.77%
323,484
-146,681
-31% -$5.06M
CDNA icon
5
CareDx
CDNA
$1.97B
$7.33M 5.17%
412,875
NVGS icon
6
Navigator Holdings
NVGS
$1.37B
$6.88M 4.85%
517,066
FRSH icon
7
Freshworks
FRSH
$3.11B
$6.64M 4.68%
470,434
EQIX icon
8
Equinix
EQIX
$103B
$6.34M 4.47%
7,778
+1,178
+18% +$1.06M
BL icon
9
BlackLine
BL
$1.8B
$6.3M 4.44%
130,050
+26,358
+25% +$1.44M
BLFS icon
10
BioLife Solutions
BLFS
$1.55B
$6.26M 4.42%
274,217
VRN
11
DELISTED
Veren
VRN
$5.9M 4.16%
890,693
AMRC icon
12
Ameresco
AMRC
$1.09B
$5.71M 4.03%
472,798
+200,104
+73% +$3.62M
VERX icon
13
Vertex
VERX
$2.04B
$5.67M 4%
161,813
+46,219
+40% +$2.11M
PROF
14
Profound Medical
PROF
$263M
$5.22M 3.68%
896,671
ETWO
15
DELISTED
E2open Parent Holdings
ETWO
$4.68M 3.3%
2,342,234
+1,171,117
+100% +$2.91M
FIVN icon
16
FIVE9
FIVN
$2.12B
$4.54M 3.21%
167,386
TMCI icon
17
Treace Medical Concepts
TMCI
$284M
$4.11M 2.9%
489,891
EXAS
18
DELISTED
Exact Sciences
EXAS
$3.77M 2.66%
86,972
PCRX icon
19
Pacira BioSciences
PCRX
$1.06B
$3.31M 2.34%
133,390
AOSL icon
20
Alpha and Omega Semiconductor
AOSL
$931M
$2.99M 2.11%
120,196
OSUR icon
21
OraSure Technologies
OSUR
$273M
$2.69M 1.89%
+797,277
New +$2.94M
KLTR icon
22
Kaltura
KLTR
$206M
$2.61M 1.84%
1,386,044
MXCT icon
23
MaxCyte
MXCT
$112M
$2.55M 1.8%
+934,196
New +$3.68M
IONQ icon
24
IonQ
IONQ
$13.4B
$2.33M 1.64%
105,589
NCNO icon
25
nCino
NCNO
$2.01B
$2.13M 1.5%
77,511

Similar funds

Gagnon Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Gagnon Advisors held 28 positions worth $142M, down 9.2% from $156M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Gagnon Advisors deployed $7.45M of net new capital in Q1 2025, opening 2 new positions and adding to 5 existing holdings. Its largest new stake was MaxCyte: 934,196 shares worth $2.55M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 31% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was GeneDx Holdings, an estimated $5.25M trimmed.

  • Gagnon Advisors's largest Q1 2025 buy was MaxCyte: 934,196 shares worth $2.55M.
  • Gagnon Advisors added most to Ameresco in Q1 2025, an estimated $3.62M increase.
  • Gagnon Advisors's biggest Q1 2025 reduction was GeneDx Holdings, cutting an estimated $5.25M.
  • Gagnon Advisors's ten largest holdings make up 57% of its $142M portfolio in Q1 2025.
  • Gagnon Advisors opened 2 new positions and closed 0 in Q1 2025.
  • Gagnon Advisors's portfolio value fell 9.2% quarter-over-quarter to $142M.

Based on Gagnon Advisors's 13F filing for Q1 2025, filed 12 May 2025.